Manifold Capital Partners LP

NEW YORK, NY · Founded 2021 · CIK 0001957326 · Biotech

High-throughput in vivo discovery engine combining multiplexed screening and AI-powered design for targeted biologics

manifold.bio →
Grants
—
No SBIR or STTR on record
Sector median: 1
Raised
$16M
1 Form D · Dec 2022
45 months since last filing
Contracts
—
No federal contracts on record
Patents
—
No published records under this name
Sector median: 2

Capital Timeline

Federal above the line · equity below · node area scaled to amount
Capital and federal award history
DateEventSourceAmount
Private capital raisedForm D · SEC$15,665,000
Form D · SEC

Peer position

Biotech · 4373 companies · ranked on federal contract value
Biotech companies ranked by federal contract value
#CompanyContractsDisclosed equity
2096MIRNA ANALYTICS, LLC——
2097Marathoner Biosciences——
2098AINGEAL, LLC——
2099Manifold Capital Partners LP—$16M
2100Aspen Neuroscience——
2101Citryll——
2102Autolus Therapeutics——

Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.

Founders & Team

From Form D filings · 1 related persons
  • -- MCP GP LLCExecutive Officer · Promoter

Regulatory activity · Biotech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.